ChristianaCare received a $1 million gift from the Bacchieri Family to support the purchase of a state-of-the-art radiography system to analyze breast cancer specimens at the Helen F. Graham Cancer Center & Research Institute and expand a fellowship program to reduce disparities in breast and lung cancer.
Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.
